InterventionsHuman trial

Semaglutide Reduces Asthma-Related Adverse Outcomes in Patients with Comorbid Asthma and Obesity: A Post Hoc Analysis of the SELECT Trial

ADA Scientific Sessions 2026 Abstract

The paper

Charlotte S. Ulrik, Kjell Erik Julius Håkansson, Søren Rasmussen,

Miquel Triana Iglesias, Howraman Meteran, Robert Kushner, Kasper Adelborg, Signe Stensen, Lotte Bjerre Knudsen,

Sheila Tuyet Tang

Copenhagen

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Poster 1723-P

doi.org/10.2337/db26-1723-p

Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
The New England Journal of Medicine · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Cell Metabolism · 8 Oct 2026